ChromaDex

company

About

ChromaDex is a provider of phytochemical standards, botanical materials, and research-grade materials for the natural products industry.

  • 101 - 250

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$5M
Industries
Biotechnology,Manufacturing,Nutraceutical,Product Research,Wellness
Founded date
Jan 1, 1999
Number Of Employee
101 - 250
Operating Status
Active

ChromaDex is a global nutraceutical company. They leverage their complementary business units to discover, acquire, develop, and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care, and pharmaceutical markets. They utilize in-house chemistry, regulatory, and safety consulting business units to develop commercially viable ingredients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$5.22M
ChromaDex has raised a total of $5.22M in funding over 2 rounds. Their latest funding was raised on Sep 30, 2014 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 30, 2014 Post-IPO Debt $5M 1 Detail
Jun 17, 2013 Grant $224.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
2
ChromaDex is funded by 2 investors. National Science Foundation and Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Hercules Capital Post-IPO Debt